Imagine a world where groundbreaking research in bioinformatics hides in obscurity, stifled by barriers that keep it from reaching the global scientific community—until now. This exciting partnership between JMIR Publications and the MidSouth Computational Biology and Bioinformatics Society (MCBIOS) promises to shatter those barriers, but here's where it gets really intriguing: will this shift redefine how we share knowledge in the digital age?
In a move that's set to transform the landscape of computational biology, JMIR Publications, a top-tier open access publisher specializing in digital health research, has teamed up with MCBIOS, a prominent group dedicated to advancing computational biology and bioinformatics. Announced from Toronto and Little Rock on November 11, 2025, this long-term collaboration officially makes JMIR Bioinformatics and Biotechnology the society's designated journal. For beginners in the field, think of this as pairing a cutting-edge research hub with a high-speed expressway: the journal now serves as the go-to platform where MCBIOS members can showcase their work, especially from the society's annual gathering.
At its heart, this Memorandum of Understanding (MOU) is about creating a dependable, influential space for publishing top-notch, peer-reviewed studies in bioinformatics and computational biology. It unites both parties in a shared goal to spread high-quality research far and wide through rapid open access. And this is the part most people miss: open access means anyone—students, researchers, or even curious enthusiasts—can read and build upon these studies without paywalls, accelerating innovation in areas like artificial intelligence and big data analytics.
But here's where it gets controversial: Some might argue that designating an 'official' journal could stifle competition or innovation by funneling all great ideas into one spot. What if this leads to a monopoly on ideas, where lesser-known voices get drowned out? We'll dive into that debate later, but for now, let's explore the tangible perks kicking in from October 10, 2025.
The alliance boosts exposure for MCBIOS members' work by leveraging JMIR's dedication to open science principles and rigorous publishing. Dr. Aik Choon Tan, MCBIOS's President, expressed his enthusiasm: 'We're thrilled to cement this collaboration with JMIR Publications. MCBIOS has long been on the hunt for a top-notch, dependable outlet for our members' innovative research, especially from our yearly conference. By choosing JMIR Bioinformatics and Biotechnology as our official journal, we're guaranteeing that vital contributions in computational biology, AI, machine learning, and big data get the spotlight and swift open access they merit, all underpinned by JMIR's open science ethos.'
To make this partnership even more appealing, JMIR will proudly feature the byline 'Official Journal of the MidSouth Computational Biology and Bioinformatics Society' and provide real-world advantages:
Specialized Annual Conference Publications: JMIR will work hand-in-hand with MCBIOS event planners to release a themed annual issue, offering a polished, searchable outlet for standout conference research. Imagine this as a curated highlight reel that turns fleeting presentations into lasting, referenced works.
Fee Reductions for Members: MCBIOS affiliates get a reduction on Article Processing Charges (APCs) for pieces approved in the journal. For those new to publishing, APCs are fees authors pay to make their work freely accessible—think of this discount as a financial boost that democratizes science, allowing more researchers to share without budget worries.
Learning Opportunities: JMIR will deliver online workshops and guidance on effective scholarly publishing, helping members navigate everything from manuscript prep to impact maximization.
Dennis O’Brien, Vice President of Communications and Partnerships at JMIR Publications, shared his perspective: 'We're honored to partner with the MidSouth Computational Biology and Bioinformatics Society to speed up the sharing of exceptional bioinformatics studies. This ties directly into our mission to support researchers via health tech and innovation. With a leading open access platform, plus perks like the yearly theme issue and member savings, we're fueling the expansion of computational biology. This setup embodies our joint drive to revolutionize academic sharing and spotlight key discoveries.'
MCBIOS will enthusiastically endorse JMIR Bioinformatics and Biotechnology as its sole publishing ally for annual events and beyond, motivating participants to submit their finest efforts.
A quick detour into controversy: Critics might wonder if this exclusivity could limit diversity in research outlets, potentially biasing what gets published. Is this the future of scientific collaboration, or a step toward homogenization? Does prioritizing 'high-impact' venues inadvertently sideline groundbreaking but unconventional ideas? Share your thoughts—do you see this as empowering or restricting?
Now, a bit about the players in this game. MCBIOS stands as a vital hub for scientists and experts, nurturing career growth and driving progress in computational biology and bioinformatics via yearly meetups, workshops, connections, and research sharing. Curious to dive deeper? Check out their site at mcbios.com.
JMIR Publications leads the charge in open access digital health publishing, advocating for open science with a focus on empowering authors and amplifying research reach. As a tech-forward entity at its core, it provides advanced tools beyond basic publishing, aiding researchers every step of the way. Their lineup includes standout journals like the Journal of Medical Internet Research. Explore more at jmirpublications.com, or follow them on Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media Contact:
Dennis O’Brien, Vice President, Communications & Partnerships
JMIR Publications
communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
So, what do you think? Does this partnership herald a new era of accessible science, or does it raise red flags about exclusivity in academia? Agree or disagree—let's discuss in the comments!
